Japan Dermatology Drug Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major Region

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Dermatology Drug market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Dermatology Drug market. Detailed analysis of key players, along with key growth strategies adopted by Dermatology Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.


    By Player:

    • Johnson&Johnson

    • MSD

    • Amgen

    • AstraZeneca

    • Novartis

    • Roche

    • Sinofi

    • Pfizer

    • GSK

    • AbbVie

    • Eli Lilly


    By Type:

    • Prescription-Based Drugs

    • OTC Drugs


    By End-User:

    • Acne

    • Dermatitis

    • Psoriasis

    • Skin Cancer

    • RosaceaAlopecia

    • Others


    By Region:

    • Hokkaido

    • Tohoku

    • Kanto

    • Chubu

    • Kinki

    • Chugoku

    • Shikoku

    • Kyushu

  • 1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Dermatology Drug Market

    • 1.3 Market Segment by Type

      • 1.3.1 Japan Dermatology Drug Market Size and Growth Rate of Prescription-Based Drugs from 2014 to 2026

      • 1.3.2 Japan Dermatology Drug Market Size and Growth Rate of OTC Drugs from 2014 to 2026

    • 1.4 Market Segment by Application

      • 1.4.1 Japan Dermatology Drug Market Size and Growth Rate of Acne from 2014 to 2026

      • 1.4.2 Japan Dermatology Drug Market Size and Growth Rate of Dermatitis from 2014 to 2026

      • 1.4.3 Japan Dermatology Drug Market Size and Growth Rate of Psoriasis from 2014 to 2026

      • 1.4.4 Japan Dermatology Drug Market Size and Growth Rate of Skin Cancer from 2014 to 2026

      • 1.4.5 Japan Dermatology Drug Market Size and Growth Rate of RosaceaAlopecia from 2014 to 2026

      • 1.4.6 Japan Dermatology Drug Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Hokkaido Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Tohoku Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Kanto Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Chubu Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Kinki Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Chugoku Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Shikoku Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Kyushu Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Dermatology Drug Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Dermatology Drug by Major Types

      • 3.4.1 Market Size and Growth Rate of Prescription-Based Drugs

      • 3.4.2 Market Size and Growth Rate of OTC Drugs


    4 Segmentation of Dermatology Drug Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Dermatology Drug by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Dermatology Drug in Acne

      • 4.4.2 Market Size and Growth Rate of Dermatology Drug in Dermatitis

      • 4.4.3 Market Size and Growth Rate of Dermatology Drug in Psoriasis

      • 4.4.4 Market Size and Growth Rate of Dermatology Drug in Skin Cancer

      • 4.4.5 Market Size and Growth Rate of Dermatology Drug in RosaceaAlopecia

      • 4.4.6 Market Size and Growth Rate of Dermatology Drug in Others


    5 Market Analysis by Regions

    • 5.1 Japan Dermatology Drug Production Analysis by Regions

    • 5.2 Japan Dermatology Drug Consumption Analysis by Regions


    6 Hokkaido Dermatology Drug Landscape Analysis

    • 6.1 Hokkaido Dermatology Drug Landscape Analysis by Major Types

    • 6.2 Hokkaido Dermatology Drug Landscape Analysis by Major End-Users


    7 Tohoku Dermatology Drug Landscape Analysis

    • 7.1 Tohoku Dermatology Drug Landscape Analysis by Major Types

    • 7.2 Tohoku Dermatology Drug Landscape Analysis by Major End-Users


    8 Kanto Dermatology Drug Landscape Analysis

    • 8.1 Kanto Dermatology Drug Landscape Analysis by Major Types

    • 8.2 Kanto Dermatology Drug Landscape Analysis by Major End-Users


    9 Chubu Dermatology Drug Landscape Analysis

    • 9.1 Chubu Dermatology Drug Landscape Analysis by Major Types

    • 9.2 Chubu Dermatology Drug Landscape Analysis by Major End-Users


    10 Kinki Dermatology Drug Landscape Analysis

    • 10.1 Kinki Dermatology Drug Landscape Analysis by Major Types

    • 10.2 Kinki Dermatology Drug Landscape Analysis by Major End-Users


    11 Chugoku Dermatology Drug Landscape Analysis

    • 11.1 Chugoku Dermatology Drug Landscape Analysis by Major Types

    • 11.2 Chugoku Dermatology Drug Landscape Analysis by Major End-Users


    12 Shikoku Dermatology Drug Landscape Analysis

    • 12.1 Shikoku Dermatology Drug Landscape Analysis by Major Types

    • 12.2 Shikoku Dermatology Drug Landscape Analysis by Major End-Users


    13 Kyushu Dermatology Drug Landscape Analysis

    • 13.1 Kyushu Dermatology Drug Landscape Analysis by Major Types

    • 13.2 Kyushu Dermatology Drug Landscape Analysis by Major End-Users


    14 Major Players Profiles

    • 14.1 Johnson&Johnson

      • 14.1.1 Johnson&Johnson Company Profile and Recent Development

      • 14.1.2 Market Performance

      • 14.1.3 Product and Service Introduction

    • 14.2 MSD

      • 14.2.1 MSD Company Profile and Recent Development

      • 14.2.2 Market Performance

      • 14.2.3 Product and Service Introduction

    • 14.3 Amgen

      • 14.3.1 Amgen Company Profile and Recent Development

      • 14.3.2 Market Performance

      • 14.3.3 Product and Service Introduction

    • 14.4 AstraZeneca

      • 14.4.1 AstraZeneca Company Profile and Recent Development

      • 14.4.2 Market Performance

      • 14.4.3 Product and Service Introduction

    • 14.5 Novartis

      • 14.5.1 Novartis Company Profile and Recent Development

      • 14.5.2 Market Performance

      • 14.5.3 Product and Service Introduction

    • 14.6 Roche

      • 14.6.1 Roche Company Profile and Recent Development

      • 14.6.2 Market Performance

      • 14.6.3 Product and Service Introduction

    • 14.7 Sinofi

      • 14.7.1 Sinofi Company Profile and Recent Development

      • 14.7.2 Market Performance

      • 14.7.3 Product and Service Introduction

    • 14.8 Pfizer

      • 14.8.1 Pfizer Company Profile and Recent Development

      • 14.8.2 Market Performance

      • 14.8.3 Product and Service Introduction

    • 14.9 GSK

      • 14.9.1 GSK Company Profile and Recent Development

      • 14.9.2 Market Performance

      • 14.9.3 Product and Service Introduction

    • 14.10 AbbVie

      • 14.10.1 AbbVie Company Profile and Recent Development

      • 14.10.2 Market Performance

      • 14.10.3 Product and Service Introduction

    • 14.11 Eli Lilly

      • 14.11.1 Eli Lilly Company Profile and Recent Development

      • 14.11.2 Market Performance

      • 14.11.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 94 Figures and 121 Tables)

     

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Prescription-Based Drugs from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of OTC Drugs from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Acne from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Dermatitis from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Psoriasis from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Skin Cancer from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of RosaceaAlopecia from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure Hokkaido Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Tohoku Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kanto Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chubu Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kinki Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Chugoku Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Shikoku Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Kyushu Dermatology Drug Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Dermatology Drug Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Dermatology Drug

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Dermatology Drug by Different Types from 2014 to 2026

    • Table Consumption Share of Dermatology Drug by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Prescription-Based Drugs

    • Figure Market Size and Growth Rate of OTC Drugs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Dermatology Drug by Different End-Users from 2014 to 2026

    • Table Consumption Share of Dermatology Drug by Different End-Users from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Acne from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Dermatitis from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Psoriasis from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Skin Cancer from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of RosaceaAlopecia from 2014 to 2026

    • Figure Japan Dermatology Drug Market Size and Growth Rate of Others from 2014 to 2026

    • Table Japan Dermatology Drug Production by Regions

    • Table Japan Dermatology Drug Production Share by Regions

    • Figure Japan Dermatology Drug Production Share by Regions in 2014

    • Figure Japan Dermatology Drug Production Share by Regions in 2018

    • Figure Japan Dermatology Drug Production Share by Regions in 2026

    • Table Japan Dermatology Drug Consumption by Regions

    • Table Japan Dermatology Drug Consumption Share by Regions

    • Figure Japan Dermatology Drug Consumption Share by Regions in 2014

    • Figure Japan Dermatology Drug Consumption Share by Regions in 2018

    • Figure Japan Dermatology Drug Consumption Share by Regions in 2026

    • Table Hokkaido Dermatology Drug Consumption by Types from 2014 to 2026

    • Table Hokkaido Dermatology Drug Consumption Share by Types from 2014 to 2026

    • Figure Hokkaido Dermatology Drug Consumption Share by Types in 2014

    • Figure Hokkaido Dermatology Drug Consumption Share by Types in 2018

    • Figure Hokkaido Dermatology Drug Consumption Share by Types in 2026

    • Table Hokkaido Dermatology Drug Consumption by End-Users from 2014 to 2026

    • Table Hokkaido Dermatology Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Hokkaido Dermatology Drug Consumption Share by End-Users in 2014

    • Figure Hokkaido Dermatology Drug Consumption Share by End-Users in 2018

    • Figure Hokkaido Dermatology Drug Consumption Share by End-Users in 2026

    • Table Tohoku Dermatology Drug Consumption by Types from 2014 to 2026

    • Table Tohoku Dermatology Drug Consumption Share by Types from 2014 to 2026

    • Figure Tohoku Dermatology Drug Consumption Share by Types in 2014

    • Figure Tohoku Dermatology Drug Consumption Share by Types in 2018

    • Figure Tohoku Dermatology Drug Consumption Share by Types in 2026

    • Table Tohoku Dermatology Drug Consumption by End-Users from 2014 to 2026

    • Table Tohoku Dermatology Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Tohoku Dermatology Drug Consumption Share by End-Users in 2014

    • Figure Tohoku Dermatology Drug Consumption Share by End-Users in 2018

    • Figure Tohoku Dermatology Drug Consumption Share by End-Users in 2026

    • Table Kanto Dermatology Drug Consumption by Types from 2014 to 2026

    • Table Kanto Dermatology Drug Consumption Share by Types from 2014 to 2026

    • Figure Kanto Dermatology Drug Consumption Share by Types in 2014

    • Figure Kanto Dermatology Drug Consumption Share by Types in 2018

    • Figure Kanto Dermatology Drug Consumption Share by Types in 2026

    • Table Kanto Dermatology Drug Consumption by End-Users from 2014 to 2026

    • Table Kanto Dermatology Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kanto Dermatology Drug Consumption Share by End-Users in 2014

    • Figure Kanto Dermatology Drug Consumption Share by End-Users in 2018

    • Figure Kanto Dermatology Drug Consumption Share by End-Users in 2026

    • Table Chubu Dermatology Drug Consumption by Types from 2014 to 2026

    • Table Chubu Dermatology Drug Consumption Share by Types from 2014 to 2026

    • Figure Chubu Dermatology Drug Consumption Share by Types in 2014

    • Figure Chubu Dermatology Drug Consumption Share by Types in 2018

    • Figure Chubu Dermatology Drug Consumption Share by Types in 2026

    • Table Chubu Dermatology Drug Consumption by End-Users from 2014 to 2026

    • Table Chubu Dermatology Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chubu Dermatology Drug Consumption Share by End-Users in 2014

    • Figure Chubu Dermatology Drug Consumption Share by End-Users in 2018

    • Figure Chubu Dermatology Drug Consumption Share by End-Users in 2026

    • Table Kinki Dermatology Drug Consumption by Types from 2014 to 2026

    • Table Kinki Dermatology Drug Consumption Share by Types from 2014 to 2026

    • Figure Kinki Dermatology Drug Consumption Share by Types in 2014

    • Figure Kinki Dermatology Drug Consumption Share by Types in 2018

    • Figure Kinki Dermatology Drug Consumption Share by Types in 2026

    • Table Kinki Dermatology Drug Consumption by End-Users from 2014 to 2026

    • Table Kinki Dermatology Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kinki Dermatology Drug Consumption Share by End-Users in 2014

    • Figure Kinki Dermatology Drug Consumption Share by End-Users in 2018

    • Figure Kinki Dermatology Drug Consumption Share by End-Users in 2026

    • Table Chugoku Dermatology Drug Consumption by Types from 2014 to 2026

    • Table Chugoku Dermatology Drug Consumption Share by Types from 2014 to 2026

    • Figure Chugoku Dermatology Drug Consumption Share by Types in 2014

    • Figure Chugoku Dermatology Drug Consumption Share by Types in 2018

    • Figure Chugoku Dermatology Drug Consumption Share by Types in 2026

    • Table Chugoku Dermatology Drug Consumption by End-Users from 2014 to 2026

    • Table Chugoku Dermatology Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Chugoku Dermatology Drug Consumption Share by End-Users in 2014

    • Figure Chugoku Dermatology Drug Consumption Share by End-Users in 2018

    • Figure Chugoku Dermatology Drug Consumption Share by End-Users in 2026

    • Table Shikoku Dermatology Drug Consumption by Types from 2014 to 2026

    • Table Shikoku Dermatology Drug Consumption Share by Types from 2014 to 2026

    • Figure Shikoku Dermatology Drug Consumption Share by Types in 2014

    • Figure Shikoku Dermatology Drug Consumption Share by Types in 2018

    • Figure Shikoku Dermatology Drug Consumption Share by Types in 2026

    • Table Shikoku Dermatology Drug Consumption by End-Users from 2014 to 2026

    • Table Shikoku Dermatology Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Shikoku Dermatology Drug Consumption Share by End-Users in 2014

    • Figure Shikoku Dermatology Drug Consumption Share by End-Users in 2018

    • Figure Shikoku Dermatology Drug Consumption Share by End-Users in 2026

    • Table Kyushu Dermatology Drug Consumption by Types from 2014 to 2026

    • Table Kyushu Dermatology Drug Consumption Share by Types from 2014 to 2026

    • Figure Kyushu Dermatology Drug Consumption Share by Types in 2014

    • Figure Kyushu Dermatology Drug Consumption Share by Types in 2018

    • Figure Kyushu Dermatology Drug Consumption Share by Types in 2026

    • Table Kyushu Dermatology Drug Consumption by End-Users from 2014 to 2026

    • Table Kyushu Dermatology Drug Consumption Share by End-Users from 2014 to 2026

    • Figure Kyushu Dermatology Drug Consumption Share by End-Users in 2014

    • Figure Kyushu Dermatology Drug Consumption Share by End-Users in 2018

    • Figure Kyushu Dermatology Drug Consumption Share by End-Users in 2026

    • Table Company Profile and Development Status of Johnson&Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson&Johnson

    • Figure Sales and Growth Rate Analysis of Johnson&Johnson

    • Figure Revenue and Market Share Analysis of Johnson&Johnson

    • Table Product and Service Introduction of Johnson&Johnson

    • Table Company Profile and Development Status of MSD

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MSD

    • Figure Sales and Growth Rate Analysis of MSD

    • Figure Revenue and Market Share Analysis of MSD

    • Table Product and Service Introduction of MSD

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of Sinofi

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sinofi

    • Figure Sales and Growth Rate Analysis of Sinofi

    • Figure Revenue and Market Share Analysis of Sinofi

    • Table Product and Service Introduction of Sinofi

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of GSK

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK

    • Figure Sales and Growth Rate Analysis of GSK

    • Figure Revenue and Market Share Analysis of GSK

    • Table Product and Service Introduction of GSK

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Eli Lilly

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly

    • Figure Sales and Growth Rate Analysis of Eli Lilly

    • Figure Revenue and Market Share Analysis of Eli Lilly

    • Table Product and Service Introduction of Eli Lilly

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.